Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Cytomegalovirus-induced T cell responses accelerate Alzheimer's disease progression in mice.

Brain : a journal of neurology·2026
Same author

Identification of a novel fiber shaft structural motif and overexpression of key transcripts elucidated in human adenovirus D 10.

PLoS pathogens·2026
Same author

Current use of pre-clinical models for evaluation of human adenovirus-based cancer therapeutics.

Molecular therapy. Oncology·2026
Same author

GP73: the key to unlocking immunotherapies efficacy in solid tumors?

Journal for immunotherapy of cancer·2025
Same author

Netrin-1 stimulated axon growth requires the polyglutamylase TTLL1.

Frontiers in neuroscience·2024
Same author

The αvβ6 integrin specific virotherapy, Ad5<sub>NULL</sub>-A20.FCU1, selectively delivers potent "in-tumour" chemotherapy to pancreatic ductal adenocarcinoma.

British journal of cancer·2024

相关实验视频

Updated: Jul 29, 2025

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

8.0K

工程 adenoviral 载体与改善的 GBM 选择性.

Emily A Bates1, Charlotte Lovatt1, Alice R Plein1

  • 1Division of Cancer and Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK.

Viruses
|May 27, 2023
PubMed
概括

对质母细胞瘤 (GBM) 的瘤性腺病毒疗法显示出有前途. 研究人员设计了腺病毒以专门针对GBM细胞,克服了标准腺病毒5 (HAdV-C5) 的局限性,并提高了治疗效率.

关键词:
大脑瘤 脑瘤科性病毒病毒.接收器 接收器 接收器接收器治疗疗法治疗疗法治疗疗法

更多相关视频

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.7K
Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds
09:18

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds

Published on: July 16, 2018

8.3K

相关实验视频

Last Updated: Jul 29, 2025

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

8.0K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.7K
Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds
09:18

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds

Published on: July 16, 2018

8.3K

科学领域:

  • 瘤治疗性病毒疗法
  • 癌症生物学 癌症生物学
  • 基因治疗是一种基因疗法.

背景情况:

  • 质母细胞瘤 (GBM) 是一种具有不良预后的侵袭性脑癌.
  • 瘤性腺病毒为GBM提供了潜在的治疗策略.
  • 人类腺病毒5 (HAdV-C5) 的使用受到先前存在的免疫和非目标效应的限制.

研究的目的:

  • 调查替代性腺病毒热流体,以改善GBM向.
  • 开发提高GBM特异性转基因表达的策略.

主要方法:

  • 亚地诺病毒平台伪型,采用替代血清型的纤维旋蛋白.
  • 在GBM和健康脑组织中对腺病毒受体表达 (CAR,CD46,DSG2) 的分析.
  • 利用瘤特异性促进体 (hTERT,survivin) 来驱动记者基因表达.

主要成果:

  • 腺病毒伪型通过CAR,CD46和DSG2.2有效地转化了GBM细胞.
  • 这些受体也存在于健康的大脑细胞上,表明潜在的非目标效应.
  • 瘤特异性促进体 (hTERT,survivin) 在GBM细胞系中表现出选择性的记者基因表达.

结论:

  • 伪型腺病毒可以增强GBM细胞转导.
  • 将伪型化与瘤特异性促进剂结合起来,提供了一种提高GBM治疗特异性的策略.
  • 这种方法可能会导致更有效,更有针对性的瘤性病毒疗法用于质母细胞瘤.